Mersana Therapeutics, Inc. (MRSN)
28.51
-0.22
(-0.77%)
USD |
NASDAQ |
Dec 30, 12:13
Mersana Therapeutics Total Liabilities (Quarterly): 122.22M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cidara Therapeutics, Inc. | 96.26M |
| Day One Biopharmaceuticals, Inc. | 62.91M |
| Semler Scientific, Inc. | 136.93M |
| Cue Biopharma, Inc. | 18.40M |
| Scholar Rock Holding Corp. | 166.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 62.69M |
| Shareholders Equity (Quarterly) | -59.54M |
| Debt to Equity Ratio | -0.0385 |
| Current Ratio | 1.386 |
| Net Debt Paydown Yield | 15.52% |